CD19 and non-Hodgkin lymphoma: We observed a significantly lower frequency of CD19+ B cells across all groups of NHL and HL patients including those receiving aCD20 ± CT, or CT alone (p = 0.0003, p = 0.0001 and p = 0.0157 respectively) compared to HC (Fig. 1C).